<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Interleukin-10 (IL-10) is a unique cytokine that is thought to be a potent immunostimulatory and immunosuppressive factor </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate IL-10 expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and clarify its relationship to the clinicopathological findings and prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Tissue samples were collected from 92 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of IL-10 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues was evaluated by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>Tissue levels of IL-10 were measured by enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The mean concentration of IL-10 did not significantly differ between the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="6" pm="."><plain>The IL-10 concentration in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue with positive staining immunohistochemically was significantly higher than that without IL-10 staining </plain></SENT>
<SENT sid="7" pm="."><plain>The IL-10 level in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue decreased in accordance with advanced-stage serosal invasion and lymph node involvement, and thus predicted poor survival in patients undergoing surgery with curative intent </plain></SENT>
<SENT sid="8" pm="."><plain>A Cox multivariate analysis demonstrated that a decreased IL-10 level in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue was an independent risk factor for poor survival </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> IL-10 level in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was inversely correlated with serosal invasion and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, which thus reflected <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Evaluating the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> expression of IL-10 may therefore provide valuable information for predicting the long-term survival in patients undergoing surgery with curative intent </plain></SENT>
</text></document>